Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series
27 Mai 2025 - 2:00PM
Business Wire
Setting new standards for intelligent mass detection,
sensitivity, and sustainability
Agilent Technologies Inc. (NYSE: A) today announced the launch
of its latest innovation in liquid chromatography (LC)-mass
detection: the Agilent InfinityLab Pro iQ Series. This
groundbreaking series includes the InfinityLab Pro iQ and the
InfinityLab Pro iQ Plus, each tailored with distinct features and
capabilities to meet the diverse analytical needs of modern
laboratories. These advanced, intelligent systems are particularly
well-suited for analyzing essential molecules such as therapeutic
small molecules, oligonucleotides, peptides, and proteins.
The Pro iQ Series is designed to serve a broad range of end
markets, including pharmaceutical and biopharmaceutical industries,
academic and government research institutions, environmental
testing labs, food safety organizations, and the chemical and
specialty materials sector. With its precision, sensitivity, and
intelligent design, the series supports applications such as mass
confirmation, impurity profiling, biomolecule characterization,
trace contaminant detection, and compound purification—empowering
scientists to achieve high-quality, reliable results in both
routine and advanced analytical workflows.
Dr. Iris Mangelschots, vice president and general manager of
Agilent’s Liquid Phase Division, emphasized the strategic
significance of the launch:
“With the launch of the Pro iQ Series, Agilent is redefining the
future of liquid chromatography detection and demonstrating our
continuing commitment to delivering leading-edge solutions to help
customers push the boundaries of scientific discovery. The advanced
Pro iQ Series will empower researchers to achieve unprecedented
levels of insight and efficiency, making complex analyses more
accessible and sustainable.”
The Pro iQ Series delivers exceptional performance and
sensitivity, making it ideal for monitoring complex biomolecules
and detecting impurities. Whether analyzing therapeutic small
molecules, oligonucleotides, peptides, or proteins, the systems
provide robust, high-resolution data to ensure accuracy, safety,
and stability. The series also enables mass-based purification,
allowing precise isolation of target compounds for downstream
applications.
The Pro iQ Plus system is engineered for high-end applications
that demand ultimate sensitivity and performance. With an expanded
mass range of m/z 2–3,000 and enhanced sensitivity through Agilent
Jet Stream (AJS) technology, it supports both routine and
trace-level detection of small and large molecules. These
capabilities make it especially valuable in advanced R&D
environments where extended analytical performance is critical.
Both the Pro iQ and Pro iQ Plus systems are designed for
operational efficiency and ease of use, enabling faster compound
confirmation with greater specificity and selectivity than
traditional UV detection—even for chromatographically unresolved
compounds. The Pro iQ system, with a mass range of m/z 2–1,600, is
optimized for small molecule analysis, making it a reliable choice
for standard laboratory workflows.
Jennifer Gushue, associate vice president of LC/MS Product
Marketing at Agilent, highlighted the broad applicability of the
new systems:
“The versatility of the Pro iQ Series opens new possibilities
across a wide spectrum of application areas—from pharmaceutical
development and quality control to biotherapeutics, environmental
testing, and academic research. Whether it's ensuring the purity of
life-saving drugs, characterizing complex biomolecules—such as
oligonucleotides and peptides—or advancing cutting-edge research,
these systems deliver the precision, sensitivity, and intelligence
today’s scientists need to solve tomorrow’s challenges.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in
analytical and clinical laboratory technologies, delivering
insights and innovation that help our customers bring great science
to life. Agilent’s full range of solutions includes instruments,
software, services, and expertise that provide trusted answers to
our customers' most challenging questions. The company generated
revenue of $6.51 billion in fiscal year 2024 and employs
approximately 18,000 people worldwide. Information about Agilent is
available at www.agilent.com. To receive the latest Agilent news,
subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250527486106/en/
Media Contact Naomi Goumillout Agilent Technologies
+1.978.314.1862 naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Graphique Historique de l'Action
De Juin 2025 à Juil 2025
Agilent Technologies (NYSE:A)
Graphique Historique de l'Action
De Juil 2024 à Juil 2025